Stay updated on SAGE-217 Safety in MDD Insomnia Clinical Trial

Sign up to get notified when there's something new on the SAGE-217 Safety in MDD Insomnia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SAGE-217 Safety in MDD Insomnia Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The sponsor of the study changed from Sage Therapeutics to Biogen, and Biogen is now listed as the sponsor and responsible party. Related sections such as the official title and sponsor information reflect Biogen’s involvement.
    Difference
    0.4%
    Check dated 2025-11-03T01:10:57.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T09:32:57.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Added a new version tag (v3.1.0) and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the page.
    Difference
    0.2%
    Check dated 2025-09-28T03:08:15.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2 and the Back to Top element was removed. No substantive changes to core content, pricing, stock, or time-related information.
    Difference
    0.1%
    Check dated 2025-09-13T17:06:02.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, and a 'Back to Top' feature has been added.
    Difference
    0.1%
    Check dated 2025-09-06T14:33:06.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically highlighting St. Louis, Missouri, and added drug information for zuranolone, while removing previous references to depression and related terms.
    Difference
    2%
    Check dated 2025-08-30T11:20:46.000Z thumbnail image

Stay in the know with updates to SAGE-217 Safety in MDD Insomnia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SAGE-217 Safety in MDD Insomnia Clinical Trial page.